Consequently, genetic variants resulting in decreased number or decreased functionality of the LDLR lead to elevated levels of LDL-cholesterol in plasma, as demonstrated in patients with familial hypercholesterolemia (FH) (OMIM#14390) (3, 4). This evidence concerns the gene LDLR and familial hyperaldosteronism.